key: cord-0716451-2uiq5g0k authors: AlZaghal, Laila A.; AlZaghal, Najwa; Alomari, Safwan O.; Obeidat, Nail; Obeidat, Basil; Hayajneh, Wail A. title: Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: A case report date: 2020-05-01 journal: Case Rep Womens Health DOI: 10.1016/j.crwh.2020.e00212 sha: 4366b468e85ac2f424f0ed21c7e1a3ad1bf41039 doc_id: 716451 cord_uid: 2uiq5g0k The SARS-COV-2 virus appears to have originated in Hubei Province in China towards the end of 2019 and has spread worldwide. Currently, there is little literature on COVID-19, and even less on its effect on pregnant mothers and infants. At this time, there are no clear recommendations specific to pregnant women with COVID-19. We report the multidisciplinary team management of a cesarean delivery for a woman infected with SARS-COV-2, including her pre-delivery care, intraoperative considerations, and post-delivery recommendations for the mother and baby. We also discuss the currently available recommendations and guidelines on the management of such cases. The SARS-COV-2 virus appears to have originated in Wuhan, the capital of Hubei Province in China, towards the end of 2019. The World Health Organization declared the virus outbreak a pandemic on March 11, 2020. (1, 2) The COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. However, other routes of transmission, including vertical transmission, are currently being studied. (3, 4) There is little literature on COVID-19, and even less on its effect on pregnant mothers and infants. At this time, there are no clear recommendations specific to pregnant women with COVID-19. To the best of our knowledge, this is the first reported cesarean delivery for a woman infected with SARS-COV-2 in Jordan and the Arab world. A 30-year-old woman, gravida 4 para 3, was admitted at 36 weeks of gestation in March 2020 after her nasopharyngeal swab tests came back positive for SARS-COV-2 using a rapid PCR technique. She complained of mild dry cough, runny nose, episodes of chills and headache three days prior to admission. She had no shortness of breath, no chest pain, and no muscle ache. On admission her vital signs were stable and she had no fever. Oxygen saturation in room air was 98%. Regarding this pregnancy, she mentioned having regular antenatal care. She reported that she had attended a social event a few days prior to presentation. Two days later, she started to have symptoms. She initially thought they were not significant but she sought medical advice many days later when a person at the same event had tested positive for SARS-COV-2. Before admission to the hospital she was living with her 2 children and husband. She was given hydroxychloroquine 400 mg twice daily for a total of 9 days. Her symptoms were mild. Her blood tests were unremarkable except for mild elevation of D-Dimer 0.65 micrograms/ml (0.1-0.5 micrograms/ml). An ultrasound scan showed appropriate baby growth for age, with average liquor and upper placenta. The mother reported good fetal J o u r n a l P r e -p r o o f Journal Pre-proof movement. On the night of her second day of admission, she started to complain of abdominal pain. Upon assessment she was found to be in labor. Her obstetric history included uncomplicated full-term vaginal delivery of her first daughter. Her second pregnancy was complicated by placental abruption and a cesarean section was done at 35 weeks of gestation. Her third pregnancy ended with a stillborn infant delivered vaginally and was complicated by severe postpartum hemorrhage requiring massive blood transfusion and surgical exploration under general anesthesia. Moreover, multiple cervical and vaginal tears were found and repaired. The decision was made to perform a cesarean section on the third day of her admission, based on patient request and maternal indications, given that she already had a caesarean section scar and that her last vaginal delivery was complicated by severe postpartum haemorrhage. Currently, there is no evidence to support one mode of delivery over another in SARS-COV-2-positive mothers. An urgent multidisciplinary meeting was held and included obstetric, neonatology, anesthesiology and infection control teams along with a well-qualified midwife and neonatal nurse. The decision was taken to prepare an isolated operating room for her, since the infection control team recommended against using a regular cesarean theatre. To reduce the risk of transmission of SARS-COV-2 to the medical team and the baby, certain precautions and recommendations were followed. The procedure was done under regional (spinal) anesthesia, the number of staff in the theatre was minimized and all were wearing appropriate PPE, including a filtering facepiece level 3 (FFP3) mask. An N95 mask was used by the patient throughout the procedure. A vigorous baby girl was born, weighing 2.5 kilograms; her APGAR score was 8 at 1 minute Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses Community transmission of severe acute respiratory syndrome coronavirus 2 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Infants Born to Mothers With a New Coronavirus (COVID-19) Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn Antibodies in Infants Born to Mothers With Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome